CA2917192A1 - Synthetic oligosaccharides for p. aeruginosa vaccine - Google Patents

Synthetic oligosaccharides for p. aeruginosa vaccine Download PDF

Info

Publication number
CA2917192A1
CA2917192A1 CA2917192A CA2917192A CA2917192A1 CA 2917192 A1 CA2917192 A1 CA 2917192A1 CA 2917192 A CA2917192 A CA 2917192A CA 2917192 A CA2917192 A CA 2917192A CA 2917192 A1 CA2917192 A1 CA 2917192A1
Authority
CA
Canada
Prior art keywords
oligosaccharide
antibody
rha
protein
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2917192A
Other languages
English (en)
French (fr)
Inventor
A. Stewart Campbell
Obadiah J. Plante
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Visterra Inc
Original Assignee
SYNGLYCO Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SYNGLYCO Inc filed Critical SYNGLYCO Inc
Publication of CA2917192A1 publication Critical patent/CA2917192A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA2917192A 2013-07-03 2014-07-01 Synthetic oligosaccharides for p. aeruginosa vaccine Abandoned CA2917192A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361842474P 2013-07-03 2013-07-03
US61/842,474 2013-07-03
PCT/US2014/045057 WO2015002954A1 (en) 2013-07-03 2014-07-01 Synthetic oligosaccharides for p. aeruginosa vaccine

Publications (1)

Publication Number Publication Date
CA2917192A1 true CA2917192A1 (en) 2015-01-08

Family

ID=52144159

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2917192A Abandoned CA2917192A1 (en) 2013-07-03 2014-07-01 Synthetic oligosaccharides for p. aeruginosa vaccine

Country Status (13)

Country Link
US (1) US20160144016A1 (enExample)
EP (1) EP3016685B1 (enExample)
JP (1) JP2016525507A (enExample)
KR (1) KR20160098161A (enExample)
CN (1) CN105517573A (enExample)
AU (1) AU2014284457A1 (enExample)
CA (1) CA2917192A1 (enExample)
CL (1) CL2015003792A1 (enExample)
HK (1) HK1217642A1 (enExample)
IL (1) IL243432A0 (enExample)
MX (1) MX2016000195A (enExample)
SG (1) SG11201510792XA (enExample)
WO (1) WO2015002954A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016138164A1 (en) * 2015-02-26 2016-09-01 Thevax Genetics Vaccine Co., Ltd. A vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific t-cell responses
CN107827981B (zh) * 2017-11-01 2019-10-25 深圳市国创纳米抗体技术有限公司 抗绿脓杆菌外毒素a的纳米抗体及其应用
CA3160266A1 (en) * 2019-12-04 2021-06-10 University Of Montana Antibacterial carbohydrate vaccine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693891A (en) * 1985-09-09 1987-09-15 Miles Laboratories, Inc. Vaccine for Pseudomonas aeruginosa
ATE458006T1 (de) * 2003-05-14 2010-03-15 Kenta Biotech Ag Humaner monoklonaler antikörper spezifisch für lipopolysacchariden (lps) des serotyps iats o6 von pseudomonas aeruginosa
CN101912609B (zh) * 2009-08-20 2012-02-01 成都蓉生药业有限责任公司 防治绿脓杆菌感染的组合物及其制备方法
CA2797052A1 (en) * 2010-04-23 2011-10-27 Ancora Pharmaceuticals Inc. Synthetic oligosaccharides for staphyloccocus vaccine
CN101947323B (zh) * 2010-07-26 2013-02-27 北京绿竹生物制药有限公司 一种革兰氏阴性细菌疫苗及其制备方法
WO2012082635A1 (en) * 2010-12-13 2012-06-21 Ancora Pharmaceuticals, Inc. Synthetic oligosaccharide group a streptococcus
EP2554549A1 (en) * 2011-08-02 2013-02-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools
EP2884842A4 (en) * 2012-07-16 2016-04-20 Visterra Inc SYNTHETIC OLIGOSACCHARIDES FOR ANTI-P. aeruginosa

Also Published As

Publication number Publication date
AU2014284457A1 (en) 2016-01-28
HK1217642A1 (zh) 2017-01-20
SG11201510792XA (en) 2016-01-28
CL2015003792A1 (es) 2017-01-20
EP3016685A4 (en) 2016-11-23
KR20160098161A (ko) 2016-08-18
MX2016000195A (es) 2016-08-18
IL243432A0 (en) 2016-03-31
CN105517573A (zh) 2016-04-20
EP3016685B1 (en) 2018-01-31
US20160144016A1 (en) 2016-05-26
JP2016525507A (ja) 2016-08-25
WO2015002954A1 (en) 2015-01-08
EP3016685A1 (en) 2016-05-11

Similar Documents

Publication Publication Date Title
WO2012082635A1 (en) Synthetic oligosaccharide group a streptococcus
AU669354B2 (en) Synthetic haemophilus influenzae conjugate vaccine
US20140170151A1 (en) Synthetic Oligosaccharides for Staphylococcus Vaccine
KR102480429B1 (ko) 스트렙토코커스 뉴모니에 혈청형 8에 대한 백신
JP2021504438A (ja) クレブシエラ ニューモニエ（Ｋｌｅｂｓｉｅｌｌａ ｐｎｅｕｍｏｎｉａｅ）に対するワクチン
JP2016183166A (ja) 炭水化物−糖脂質共役ワクチン
WO2012145626A1 (en) Synthetic oligosaccharides for staphylococcus vaccine
US11420993B2 (en) Semi-synthetic meningococcal conjugate vaccine
WO2011149778A1 (en) Synthetic oligosaccharides for neisseria meningitis vaccine
EP3016685B1 (en) Synthetic oligosaccharides for p. aeruginosa vaccine
WO2012138698A1 (en) Synthesis of beta-mannuronic acid oligosaccharides
JP6630440B2 (ja) ストレプトコッカス ニューモニアエ（Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅ）血清型２に対する合成ワクチン
US9447133B2 (en) Synthetic oligosaccharides for moraxella vaccine
WO2014014670A1 (en) Synthetic oligosaccharides for p. aeruginosa vaccine
CZ2002721A3 (cs) Směsi oligosacharidů, způsob jejich syntézy a syntézy disacharidu meziproduktu a derivátů disacharidu, imunogen, vakcina, makromolekuly a pouľití disacharidů a makromolekul
WO2012103058A1 (en) Method for synthesizing glucans with beta-1,3 and beta-1,6 linkages
WO2018144799A1 (en) Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190703